Relugolix
Cat.No:IR0760 Solarbio
CAS:737789-87-6
Molecular Formula:C29H27F2N7O5S
Molecular Weight:623.63
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > GPCR & G Protein > RelugolixCAS:737789-87-6
Molecular Formula:C29H27F2N7O5S
Molecular Weight:623.63
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 737789-87-6 |
| Name | Relugolix |
| Molecular Formula | C29H27F2N7O5S |
| Molecular Weight | 623.63 |
| Solubility | Soluble in DMSO |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| MDL | MFCD25976856 |
| SMILES | O=C(NOC)NC1=CC=C(C(S2)=C(CN(C)C)C(C(N3C4=NN=C(OC)C=C4)=O)=C2N(CC5=C(F)C=CC=C5F)C3=O)C=C1 |
| Target Point | GNRH Receptor |
| Passage | GPCR & G Protein |
| Background | Relugolix is a selective gonadotropin-releasing hormone receptor (GnRHR) antagonist. |
| Biological Activity | Relugolix (TAK-385) is a potent,orally active,nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209)[1]. Relugolix is used for the study of sex-hormone-dependent diseases,such as including endometriosis,uterine fibroids and prostate cancer et al[2]. |
| IC50 | IC50: 0.33 nM (human GnRH).IC50: 0.32 nM (monkey GnRH)[2] |
| Data Literature Source | [1]. Kazuhiro Miwa,et al. Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent,Orally Active,Non-Peptide Antagonis [2]. Daisuke Nakata,et al. Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix),a novel,investigational,orally active,small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice. E |
| Unit | Bottle |
| Specification | 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download